(Q35543165)

8 August 2017

1 reference

title

The biology and therapy of adult acute lymphoblastic leukemia (English)

1 reference

8 August 2017

lymphoblastic leukemia

1 reference

genetic predisposition to disease

inferred from title

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14508819

14 March 2024

1 reference

14 March 2024

3

Hagop M Kantarjian

1 reference

8 August 2017

1

Stefan Faderl

1 reference

8 August 2017

2

Sima Jeha

1 reference

8 August 2017

Hagop M. Kantarjian

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14508819

14 March 2024

language of work or name

English

0 references

publication date

1 October 2003

1 reference

full work available at URL

8 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcncr.11664

1 reference

https://onlinelibrary.wiley.com/doi/full/10.1002/cncr.11664

14 March 2024

1 reference

14 March 2024

1 reference

8 August 2017

98

1 reference

8 August 2017

7

1 reference

8 August 2017

1337-1354

1 reference

Surface immunoglobulin light chain-positive acute lymphoblastic leukemia of FAB L1 or L2 type: a report of 6 cases in adults

8 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

Chemotherapy compared with bone marrow transplantation for adults with acute lymphoblastic leukemia in first remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

Temperature dependent change of apparent diffusion coefficient of water in normal and ischemic brain of rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

Myeloid antigen, CD13, CD14, and/or CD33 expression is restricted to certain lymphoid neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

CD117/CD34 expression in leukemic blasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

Long-term follow-up of adults with acute lymphoblastic leukemia in first remission treated with chemotherapy or bone marrow transplantation. The Acute Lymphoblastic Leukemia Working Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

21 January 2018

Cancer statistics, 2001

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Acute lymphoblastic leukemia. A comprehensive review with emphasis on biology and therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

LYMPHOBLASTIC LEUKAEMIA IN SIAMESE TWINS: EVIDENCE FOR IDENTITY

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Down syndrome and acute leukemia in children: A 10-year retrospective survey from Childrens Cancer Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Down's syndrome and leukemia: epidemiology, genetics, cytogenetics and mechanisms of leukemogenesis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Down's syndrome and acute lymphoblastic leukaemia: clinical features and response to treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Relationship of chromosome 21 and acute leukemia in children with Down syndrome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Congenital abnormalities in children with acute leukemia: a report from the Children's Cancer Group.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Acute lymphoblastic leukemia and Klinefelter's syndrome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Ataxia-telangiectasia and acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Incidence of leukemia in atomic bomb survivors belonging to a fixed cohort in Hiroshima and Nagasaki, 1950--71. Radiation dose, years after exposure, age at exposure, and type of leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Mortality from cancer and other causes after radiotherapy for ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Radiation dose effects in relation to obstetric x-rays and childhood cancers.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Acute Leukemia and Residential Proximity to Potential Sources of Environmental Pollutants

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Acute leukemia in professional drivers exposed to gasoline and diesel

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Cigarette smoking and adult leukemia. A meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Parental medication use and risk of childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Acute leukemia in electrical workers: a New Zealand case-control study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Pathogenesis of Burkitt lymphoma: expression of an activated c-myc oncogene causes the tumorigenic conversion of EBV-infected human B lymphoblasts

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Season-of-birth and acute leukemia of infancy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

A hypothesis concerning deficiency of sunlight, cold temperature, and influenza epidemics associated with the onset of acute lymphoblastic leukemia in northern Finland

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Acute lymphoid leukemia with t(4;11) (q21;q23) following chemotherapy with cytostatic agents targeting at DNA-topoisomerase II

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Cutaneous lymphocytic vasculitis as the presenting feature of acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Bilateral optic disk edema and blindness as initial presentation of acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Central nervous system involvement in adult acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

T-cell blast crisis of chronic myelogenous leukemia manifesting as a large mediastinal tumor

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Mediastinal mass in childhood T-cell acute lymphoblastic leukemia: significance and therapy response

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

B cell acute lymphocytic leukemia in adults. Clinical, morphologic, and immunologic findings

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Burkitt's acute lymphocytic leukemia (L3ALL) in adults

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

https://api.crossref.org/works/10.1002%2FCNCR.11664

1 reference

7 January 2021

Two cases of acute lymphocytic leukaemia associated with bone marrow necrosis--a brief review of recent literature

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Bone marrow necrosis: clinicopathologic analysis of 20 cases and review of the literature

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Proposals for the Classification of the Acute Leukaemias French-American-British (FAB) Co-operative Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

The morphological classification of acute lymphoblastic leukaemia: concordance among observers and clinical correlations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Prognostic significance of the revised French-American-British classification for acute lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Myeloperoxidase gene expression in acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Immunophenotypic classification of acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Pre-B-cell leukemia. A new phenotype of childhood lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Acute lymphoid leukemia in adolescents: clinical and biologic features predict a poor prognosis--a Pediatric Oncology Group Study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Pathologic diagnosis of acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

The immunophenotype of 325 adult acute leukemias: relationship to morphologic and molecular classification and proposal for a minimal screening program highly predictive for lineage discrimination

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Myeloid antigen co-expression in childhood acute lymphoblastic leukaemia: relationship with in vitro drug resistance.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

The value of c-kit in the diagnosis of biphenotypic acute leukemia. EGIL (European Group for the Immunological Classification of Leukaemias)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Reappraisal of the clinical and biologic significance of myeloid-associated antigen expression in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Is the scoring system an effective clinico-biological tool in myeloid antigen positive adult acute lymphoblastic leukemia? Results of a long-term study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Myeloid markers in adult acute lymphocytic leukemia. Correlations with patient and disease characteristics and with prognosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

The biology of chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Philadelphia-chromosome-positive adult acute lymphocytic leukemia: characteristics, treatment results, and prognosis in 41 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Incidence and clinical significance of CDKN2/MTS1/P16ink4A and MTS2/P15ink4B gene deletions in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Genetic studies of childhood acute lymphoblastic leukemia with emphasis on p16, MLL, and ETV6 gene abnormalities: results of St Jude Total Therapy Study XII

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Cytogenetics adds independent prognostic information in adults with acute lymphoblastic leukaemia on MRC trial UKALL XA. MRC Adult Leukaemia Working Party.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

The absence of the p15INK4B gene alterations in adult patients with precursor B-cell acute lymphoblastic leukaemia is a favourable prognostic factor

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

General Report on the European Union Concerted Action Workshop on 11q23, London, UK, May 1997

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Ten novel 11q23 chromosomal partner sites. European 11q23 Workshop participants

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

TEL-AML1 fusion in acute lymphoblastic leukaemia of adults

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Chromosomal translocations in human cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

It's ALL in the diagnosis.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Molecular classification of cancer: class discovery and class prediction by gene expression monitoring

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Insights into the biologic and molecular abnormalities in adult acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Early response to induction therapy as a predictor of disease-free survival and late recurrence of childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Time to platelet recovery predicts outcome of patients with de novo acute lymphoblastic leukaemia who have achieved a complete remission

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Treatment of Adult ALL according to protocols of the German Multicenter Study Group for Adult ALL (GMALL).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

The Medical Research Council trials in adult acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Recent clinical trials in acute lymphocytic leukemia by the Cancer and Leukemia Group B.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Intensified and shortened cyclical chemotherapy for adult acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Intensification of treatment for adults with acute lymphoblastic leukaemia: results of U.K. Medical Research Council randomized trial UKALL XA. Medical Research Council Working Party on Leukaemia in Adults

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Estimated 6-year event-free survival of 55% in 60 consecutive adult acute lymphoblastic leukemia patients treated with an intensive phase II protocol based on high induction dose of daunorubicin

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Chemotherapy of adult acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Acute lymphocytic leukaemia in the elderly: characteristics and outcome with the vincristine-adriamycin-dexamethasone (VAD) regimen

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Experience with vincristine, doxorubicin, and dexamethasone (VAD) chemotherapy in adults with refractory acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Lower incidence of meningeal leukemia when prednisone is replaced by dexamethasone in the treatment of acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Nation-wide randomized comparative study of doxorubicin, vincristine and prednisolone combination therapy with and without L-asparaginase for adult acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Recent approaches in acute lymphoblastic leukemia in adults

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Cytarabine with high-dose mitoxantrone induces rapid complete remissions in adult acute lymphoblastic leukemia without the use of vincristine or prednisone

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

High efficacy of the German multicenter ALL (GMALL) protocol for treatment of adult acute lymphoblastic leukemia (ALL)--a single-institution study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Duration and intensity of maintenance chemotherapy in acute lymphoblastic leukaemia: overview of 42 trials involving 12 000 randomised children

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

The GIMEMA ALL 0183 trial: analysis of 10-year follow-up. GIMEMA Cooperative Group, Italy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

The increasing incidence of central nervous system leukemia in children. (Children's Cancer Study Group A).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Report and recommendations of the Rome workshop concerning poor-prognosis acute lymphoblastic leukemia in children: biologic bases for staging, stratification, and treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Low leukocyte counts with blast cells in cerebrospinal fluid of children with newly diagnosed acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Hyper-CVAD program in Burkitt's-type adult acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Allogeneic bone marrow transplantation for acute lymphoblastic leukemia during first complete remission

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Allogeneic stem cell transplantation for acute lymphocytic leukemia in adults

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Allogeneic bone marrow transplantation in adult acute lymphoblastic leukemia in first complete remission: a comparative study. French Group of Therapy of Adult Acute Lymphoblastic Leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Adult acute lymphocytic leukemia study testing chemotherapy and autologous and allogeneic transplantation. A follow-up report of the French protocol LALA 87.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Results of the vincristine, doxorubicin, and dexamethasone regimen in adults with standard- and high-risk acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

The role of posttransplantation maintenance chemotherapy in improving the outcome of autotransplantation in adult acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Studies of minimal residual disease in acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer--Childhood Leukemia Cooperative Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Molecular detection of minimal residual disease in adult and childhood acute lymphoblastic leukaemia reveals differences in treatment response

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Minimal residual disease tests provide an independent predictor of clinical outcome in adult acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Salvage therapy for refractory or relapsed acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

The hyper-CVAD regimen improves outcome in relapsed acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Combination therapy with methotrexate, vincristine, polyethylene-glycol conjugated-asparaginase, and prednisone in the treatment of patients with refractory or recurrent acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Short-term intensive treatment (V.A.A.P.) of adult acute lymphoblastic leukemia and lymphoblastic lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Fludarabine and cytosine arabinoside in the treatment of refractory or relapsed acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

FLAG-idarubicin and allogeneic stem cell transplantation for Ph-positive ALL beyond first remission

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

BONE-MARROW TRANSPLANTATION IN HIGH-RISK ACUTE LYMPHOBLASTIC LEUKAEMIA IN FIRST AND SECOND REMISSION

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Philadelphia chromosome-positive acute lymphoblastic leukemia- current concepts and future perspectives

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Attempts to improve treatment outcomes in acute myeloid leukemia (AML) in older patients: the results of the United Kingdom Medical Research Council AML11 trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoid leukemias

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Improved survival rate in children with stage III and IV B cell non-Hodgkin's lymphoma and leukemia using multi-agent chemotherapy: results of a study of 114 children from the French Pediatric Oncology Society

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Improved survival for children with B-cell acute lymphoblastic leukemia and stage IV small noncleaved-cell lymphoma: a pediatric oncology group study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone and highly active antiretroviral therapy for patients with acquired immunodeficiency syndrome-related Burkitt lymphoma/leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Paraneoplastic myasthenia gravis correlates with generation of mature naive CD4+ T cells in thymomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Eighty-one percent event-free survival in advanced Burkitt's lymphoma/leukemia: no differences in outcome between pediatric and adult patients treated with the same intensive pediatric protocol

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

Burkitt cell acute leukaemia (L3 ALL) in adults: a report of 18 cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11664

7 January 2021

[Acute lymphoblastic leukemia in children with Fanconi anemia]

15

1 reference

An infectious etiology for common acute lymphoblastic leukemia in childhood?

14 March 2024

27

1 reference

Preleukaemic states in children

14 March 2024

40

1 reference

Consensus protocol for the flow cytometric immunophenotyping of hematopoietic malignancies. Working Group on Flow Cytometry and Image Analysis

14 March 2024

50

1 reference

Proposals for the immunological classification of acute leukemias

14 March 2024

51

1 reference

Cytogenetic studies in 30 patients with Burkitt's lymphoma or L3 acute lymphoblastic leukemia with special reference to additional chromosome abnormalities

14 March 2024

58

1 reference

Myeloid surface antigen expression in adult acute lymphoblastic leukemia

14 March 2024

67

1 reference

Association of chromosome arm 9p abnormalities with adverse risk in childhood acute lymphoblastic leukemia: A report from the Children's Cancer Group

14 March 2024

82

1 reference

The prognostic significance of p16INK4a/p14ARF and p15INK4b deletions in adult acute lymphoblastic leukemia

14 March 2024

84

1 reference

TEL/AML1 fusion gene is a rare event in adult acute lymphoblastic leukemia

14 March 2024

93

1 reference

Which factors influence the different outcome of therapy in adults and children with ALL?

14 March 2024

105

1 reference

Phase III trial of brief intensive treatment of adult acute lymphocytic leukemia comparing daunorubicin and mitoxantrone: a CALGB Study

14 March 2024

140

1 reference

Adult acute lymphocytic leukemia: the Eastern Cooperative Oncology Group experience

14 March 2024

141

1 reference

Prophylaxis and treatment of leukemia in the central nervous system and other sanctuaries

14 March 2024

145

1 reference

Bone marrow transplantation in 63 adult patients with acute lymphoblastic leukemia in first complete remission

14 March 2024

163

1 reference

Report from the International Bone Marrow Transplant Registry

14 March 2024

179

1 reference

Feasibility and timing of unrelated donor identification for patients with ALL

14 March 2024

182

1 reference

Prospective karyotype analysis in adult acute lymphoblastic leukemia: the cancer and leukemia Group B experience

14 March 2024

184

1 reference

14 March 2024

Identifiers

DOI

10.1002/CNCR.11664

1 reference

8 August 2017

1 reference